C CELGENE

Welcome to the Brand page for “C CELGENE”, which is offered here for Educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; education services, providing mentoring, tutoring, classes, seminars, and workshops in the fields of highlighting the advancements made in cancer treatments and discussing the importance of continuing research to develop innovative new treatments;the mark consists of a blue design in the shape of a c with the words celgene in blue.;pharmaceutical preparations for use in the treatment of immunological, inflammatory and neurological disorders;c cell gene;the color(s) blue is/are claimed as a feature of the mark.;administration of patient reimbursement programs; administering pharmacy reimbursement programs and services;providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer;development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; providing an interactive web site that enables users to enter, access, track, monitor and generate health and medical information and reports; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, development of pharmaceuticals or diagnostic methods for others;.

Its status is currently believed to be active. Its class is unavailable. “C CELGENE” is believed to be currently owned by “Celgene Corporation”.